Pherin Corporation

Pherin Pharmaceuticals, Inc.

Luis Monti-Bloch

David L Berliner

Clive L Jennings-White

Nathan W Adams

The invention relates to a method of alleviating pain. The method comprises nasally administering a steroid which is a human vomeropherin, such that the vomeropherin binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers.

Steroids as neurochemical stimulators of the VNO to alleviate pain

The invention relates to a method of alleviating the symptoms of PMS and anxiety. The method comprises nasally administering a steroid which is a human vomeropherin, such that the vomeropherin binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers.

Steroids as neurochemical stimulators of the VNO to treat paroxistic

Steroids as neurochemical stimulators of the VNO to alleviate symptoms

The invention relates to combined neuroepithelial electrode and sample delivery devices which deliver a stimulant to neuroepithelial tissue and measure the bioelectric response of the tissue to the stimulant. Some devices also include an evacuation catheter which removes the stimulant from a subject immediately after stimulation, thereby limiting the locus of stimulated tissue. The invention also relates to methods of using these devices to stimulate and measure the response of neuroepithelial tissue, particularly the neuroepithelial tissue of the human vomeronasal organ.

Growing community of inventors

Salt Lake City, UT, United States of America

Luis Monti-Bloch